Share chart Perspective Therapeutics, Inc.
Extended chart
Simple chart
About Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. more detailsIPO date | 2005-11-10 |
---|---|
ISIN | US46489V1044 |
Industry | Health Care Equipment & Supplies |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.perspectivetherapeutics.com |
Цена ао | 2.27 |
Change price per day: | -0.7317% (2.05) |
---|---|
Change price per week: | +19.01% (1.71) |
Change price per month: | -21.43% (2.59) |
Change price per 3 month: | -36.41% (3.2) |
Change price per half year: | -84.35% (13) |
Change price per year: | +33.01% (1.53) |
Change price per 3 year: | +498.53% (0.34) |
Change price per 5 year: | +270% (0.55) |
Change price per year to date: | -44.25% (3.65) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Vanguard Group Inc | 13213750 | 2.25 |
Baker Brothers Advisors, LLC | 7639703 | 1.3 |
Blackrock Inc. | 4538389 | 0.77 |
Geode Capital Management, LLC | 2516649 | 0.43 |
Ghost Tree Capital, LLC | 1600000 | 0.27 |
Osterweis Capital Management, Inc. | 1582100 | 0.27 |
HighTower Advisors, LLC | 1332238 | 0.23 |
Perkins Capital Management, Inc. | 700000 | 0.12 |
State Street Corporation | 671524 | 0.11 |
Taylor & Morgan Wealth Management, LLC | 625000 | 0.11 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
iShares Morningstar Small-Cap Growth ETF | 0.02697 | 596.94 | 0.72598 |
iShares Morningstar Small-Cap ETF | 0.01351 | 391.25 | 1.60498 |
0.02 | 494.1 | 1.17 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Johan M. Spoor | CEO & Director | 855.78k | 1972 (53 years) |
Mr. Jonathan R. Hunt | CFO and Principal Financial & Accounting Officer | 944.35k | 1967 (58 years) |
Mr. Shane Cobb | Executive Vice President of Operations | N/A | |
Dr. Michael K. Schultz Ph.D. | Chief Science Officer | N/A | |
Mr. Andrew Bright | Executive Vice President of Brachytherapy | N/A | |
Dr. Markus Puhlmann M.B.A., M.D. | Chief Medical Officer | 633.14k | 1966 (59 years) |
Mr. Amos Hedt BA, PGradDip | Chief Business Strategy Officer | N/A | |
Dr. Frances L. Johnson M.D. | Chief Innovation Officer | N/A | |
Mr. David Hauser Ph.D. | Senior Vice President of Clinical Operations | N/A | |
Steve Keefe | Senior Vice President of Clinical Development |
Address: United States, Richland. WA, 350 Hills Street - open in Google maps, open in Yandex maps
Website: https://www.perspectivetherapeutics.com
Website: https://www.perspectivetherapeutics.com